The mercurial and Twitter-obsessed Tesla ($TSLA) CEO changed his handle overnight to "Elon Tusk" with an elephant emoji, and tweeted that there would be "some Tesla news" coming at 2 p.m. on Thursday.
A master of capturing media attention, Musk could be teasing a gimmicky Tesla feature, à la "Dog Mode," that would deflect some of the scrutiny he is once again under for tangling with the SEC over its regulatory practices. Or he could make a more serious announcement related to Model 3 production targets, or even how the company plans to pay off a $920 million convertible bond due on the first of the month.
The point is: no one knows ー and that's the problem. Earlier this week the SEC complained that Musk should be held in contempt for continuing to tweet market-moving investor information without prior sign-off from Tesla lawyers, which was part of Musk's settlement agreement with the agency.
That became infinitely more difficult when the company's general counsel quit last week after just two months.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
Shan Aggarwal, VP of Corporate and Business Development at Coinbase, discusses the company's acquisitio of Deribit as it heads into the S&P 500. Watch!
Shopping expert Trae Bodge discusses how talks between the U.S. and China is good news for now, but uncertainty remains for back-to-school and the holidays.
Jake Traylor, White House reporter at Politico, joins Cheddar to discuss how Trump is aiming to lower drug prices and how it differs from Biden's approach.
